Six Ratings Lowered And 32 Ratings Affirmed On Eight Asset Repackaging Vehicle RMBS Re-REMIC Deals Issued In 2009 Dec 11

  • ID: 2030441
  • December 2011
  • Standard & Poors
1 of 3

OVERVIEW We reviewed eight Asset Repackaging Vehicle Ltd. RMBS re-REMIC transactions issued in 2009 based on revisions to payment priorities within these structures. We lowered our ratings on six classes from two transactions and removed three of them from CreditWatch with negative implications. We affirmed our ratings on 32 classes from seven transactions and removed 26 of them from CreditWatch negative. We also withdrew our ratings on two classes that were paid in full. We based our rating actions on our analysis of expected payments of interest and principal, when applicable, to these classes of securities under our applicable rating scenario stresses. NEW YORK (Standard & Poor's) Dec. 9, 2011--Standard & Poor's Ratings Services today lowered its ratings on six...

Companies mentioned in this report are:
- Asset Repackaging Vehicle Ltd.

Action: Affirmed
Action: Downgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Asset Repackaging Vehicle Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.